Evidence map›Paper›PMID 23499431›Full record

ReviewFEBS letters2013

Exploring the accessible conformations of N-terminal acetylated α-synuclein.

Gina M Moriarty, Maria K Janowska, Lijuan Kang, Jean Baum

Open access · greenAbstract readReview
In one paragraph

Review in FEBS letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  3. Article
  4. Biometals as conformational modulators of α-synuclein photochemical crosslinking.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2019
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gina M MoriartyDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA.
Maria K Janowska
Lijuan Kang
Jean Baum
Rutgers, The State University of New Jersey · US

Funding

Experiments & Computations to Find Aggregation-Prone Ensembles of Alpha-SynucleinR01GM087012 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI BAUM, JEAN S, LEVY, RONALD · 2009 to 2010
$607k
NIGMS NIH HHS GM087012NIGMS NIH HHS R01 GM087012
6 · The paper itself

Abstract

Alpha synuclein (αsyn) fibrils are found in the Lewy Bodies of patients with Parkinson's disease (PD). The aggregation of the αsyn monomer to soluble oligomers and insoluble fibril aggregates is believed to be one of the causes of PD. Recently, the view of the native state of αsyn as a monomeric ensemble was challenged by a report suggesting that αsyn exists in its native state as a helical tetramer. This review reports on our current understanding of αsyn within the context of these recent developments and describes the work performed by a number of groups to address the monomer/tetramer debate. A number of in depth studies have subsequently shown that both non-acetylated and acetylated αsyn purified under mild conditions are primarily monomer. A description of the accessible states of acetylated αsyn monomer and the ability of αsyn to self-associate is explored.

Indexed as

Protein ConformationProtein MultimerizationProtein Structure, SecondaryAcetylationalpha-SynucleinHumansLewy BodiesParkinson Diseasealpha-Synuclein

Identifiers

PMID23499431
PMCPMC4201235
OpenAlexW2071469491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.